Free Trial
NASDAQ:KOD

Kodiak Sciences (KOD) Stock Price, News & Analysis

Kodiak Sciences logo
$4.53 +0.04 (+0.89%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$4.58 +0.05 (+1.10%)
As of 07/11/2025 05:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Kodiak Sciences Stock (NASDAQ:KOD)

Key Stats

Today's Range
$4.32
$4.54
50-Day Range
$3.33
$4.92
52-Week Range
$1.92
$11.60
Volume
278,336 shs
Average Volume
346,018 shs
Market Capitalization
$239.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.00
Consensus Rating
Hold

Company Overview

Kodiak Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
82nd Percentile Overall Score

KOD MarketRank™: 

Kodiak Sciences scored higher than 82% of companies evaluated by MarketBeat, and ranked 202nd out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Kodiak Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 1 hold rating, and 1 sell rating.

  • Amount of Analyst Coverage

    Kodiak Sciences has received no research coverage in the past 90 days.

  • Read more about Kodiak Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for Kodiak Sciences are expected to decrease in the coming year, from ($3.45) to ($3.82) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Kodiak Sciences is -1.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Kodiak Sciences is -1.25, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Kodiak Sciences has a P/B Ratio of 1.58. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Kodiak Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    4.54% of the float of Kodiak Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Kodiak Sciences has a short interest ratio ("days to cover") of 5.6.
  • Change versus previous month

    Short interest in Kodiak Sciences has recently increased by 8.33%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Kodiak Sciences does not currently pay a dividend.

  • Dividend Growth

    Kodiak Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.54% of the float of Kodiak Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    Kodiak Sciences has a short interest ratio ("days to cover") of 5.6.
  • Change versus previous month

    Short interest in Kodiak Sciences has recently increased by 8.33%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Kodiak Sciences has a news sentiment score of 0.58. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Kodiak Sciences this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for KOD on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Kodiak Sciences to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Kodiak Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    45.90% of the stock of Kodiak Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    89.06% of the stock of Kodiak Sciences is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Kodiak Sciences' insider trading history.
Receive KOD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kodiak Sciences and its competitors with MarketBeat's FREE daily newsletter.

KOD Stock News Headlines

Penny Stocks To Watch In July 2025
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Kodiak Sciences to Host Investor R&D Day on July 16, 2025
See More Headlines

KOD Stock Analysis - Frequently Asked Questions

Kodiak Sciences' stock was trading at $9.95 at the start of the year. Since then, KOD shares have decreased by 54.5% and is now trading at $4.53.

Kodiak Sciences Inc. (NASDAQ:KOD) issued its quarterly earnings data on Wednesday, May, 14th. The company reported ($1.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.89) by $0.20.

Kodiak Sciences (KOD) raised $126 million in an initial public offering (IPO) on Thursday, October 4th 2018. The company issued 9,000,000 shares at $13.00-$15.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Barclays and Chardan were co-managers.

Shares of KOD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kodiak Sciences investors own include NVIDIA (NVDA), Datadog (DDOG), CrowdStrike (CRWD), Tesla (TSLA), Meta Platforms (META), Advanced Micro Devices (AMD) and Splunk (SPLK).

Company Calendar

Last Earnings
5/14/2025
Today
7/12/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:KOD
CIK
1468748
Fax
N/A
Employees
90
Year Founded
N/A

Price Target and Rating

High Price Target
$20.00
Low Price Target
$3.00
Potential Upside/Downside
+98.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.63)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$176.21 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-115.71%
Return on Assets
-54.17%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.62
Quick Ratio
4.62

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.86 per share
Price / Book
1.58

Miscellaneous

Outstanding Shares
52,760,000
Free Float
28,545,000
Market Cap
$239.00 million
Optionable
Optionable
Beta
2.28
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:KOD) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners